Test Code 9193U

Test Name Methylphenidate and Metabolite Screen, Urine

Purpose
Exclusion Screen
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80307
New York State Approval Status

Approved

Turnaround Time

8 days (If Positive: 15 days)

Test Includes
1 Methylphenidate Ritalin® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 10 Stimulant
2 Ritalinic Acid Methylphenidate Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 50 Stimulant

Test Also Known As
Concerta®; Focalin; Methidate®
Reflex Tests
Test Code Test Name
5132U Methylphenidate and Metabolite Confirmation, Urine
Compliance Statement
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
Specimen Type
Urine
Requested Volume
2 mL
Minimum Volume
0.6 mL
Special Handling
None
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
Received Room Temperature.

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: Not Stable
Refrigerated: 20 day(s)
Frozen (-20 °C): 5 month(s)
1 Methylphenidate Ritalin® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 10 Stimulant
2 Ritalinic Acid Methylphenidate Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 50 Stimulant

Interface Map

LOINC® Information

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.